This higher-strength fixed-dose combination of Glimepiride and prolonged-release Metformin Hydrochloride is formulated for patients requiring an intensified antidiabetic regimen, combining insulin secretagogue and biguanide mechanisms.

Each unit of this high-strength antidiabetic combination tablet contains Glimepiride IP 1 mg + Metformin Hydrochloride IP 1000 mg (prolonged release), formulated in tablets form and manufactured in compliance with Indian Pharmacopoeia (IP) standards. This ensures uniform potency and quality across every production batch, a key requirement for pharmaceutical importers and distributors evaluating type 2 diabetes fixed-dose therapy medication for their regional markets.

Used in the management of type 2 diabetes mellitus in patients requiring a higher-dose combination regimen, under physician guidance. Suitable for hospital and pharmacy distribution.

Packed in 10x10 blister strips, ensuring product stability across long-distance export logistics. The 10x10 Tablets configuration is widely used in international pharmaceutical trade, supporting efficient inventory management for wholesalers and institutional buyers sourcing glimepiride metformin combination formulation in bulk quantities.

CD&M Remedies is an established manufacturer of IP-compliant pharmaceutical formulations, supplying high-strength antidiabetic combination tablet to B2B buyers and importers worldwide. Buyers benefit from consistent formulation quality, reliable supply capability, and export-oriented packing suited to cross-border pharmaceutical trade.

Q: What is the composition of Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M1 Forte?
A: It contains Glimepiride IP 1 mg + Metformin Hydrochloride IP 1000 mg (prolonged release), manufactured to Indian Pharmacopoeia (IP) standards in tablets form.

Q: What pack sizes are available for Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M1 Forte?
A: This product is supplied in 10x10 Tablets export packing, suitable for wholesale and institutional bulk orders.

Q: Who manufactures Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M1 Forte?
A: Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M1 Forte is manufactured and supplied by CD&M Remedies, under product code 1005.

Q: Which product category does Metformin Hydrochloride Prolonged Release And Glimepiride Tablets IP Cdpride-M1 Forte belong to?
A: It falls under the Anti-Diabetic Combination Medication category, intended for B2B pharmaceutical buyers and importers.